Breast Tumor clinical trials at UCSF

1 research study open to eligible people

A breast tumor is an abnormal growth in the breast. UCSF is studying new medicines given before surgery to measure how cancers shrink. UCSF is matching test results to drugs to find the best fits.

Showing trials for

  • I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

    San Francisco, California and other locations

Our lead scientists for Breast Tumor research studies include .

Last updated: